Skip to main content
. Author manuscript; available in PMC: 2014 Nov 15.
Published in final edited form as: Clin Cancer Res. 2013 Oct 4;19(22):6101–6111. doi: 10.1158/1078-0432.CCR-12-3669

Table 1.

Univariate analysis showed that patients with high level of S4F had <5-fold increase of risk for biochemical recurrence compared with those with low level of S4F [HR=5.426 (hazard ratio, 5.426 (95% confidence interval, 2.19–13.40); P = 0.0002]. S4F was an independent indicator for biochemical recurrence. [hazard ratio, 7.551 (95% confidence interval, 2.345–24.312); P = 0.000].

Univariate HR 95.0% CI for HR p-value
Lower Upper
S4F Epi Cyto (groups) 5.43 2.20 13.40 .0002
Multivariate HR 95.0% CI for HR
p-value
Lower Upper

Ln (PSA) 2.03 1.14 3.60 .0160
LN 21.59 6.84 68.17 <0.0001
ECE 1.67 .53 5.25 .3811
SVI 1.25 .47 3.38 .6534
MARGINS 5.22 1.91 14.29 .0013
Gleason Grade 4.70 1.88 11.72 .0009
S4F Epi Cyto (groups) 7.55 2.35 24.31 .0007